AceView: Gene:RND3, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
DC299174		.a	1 to 554	2 to 556		tiling clone,		556/556 (100 %)	2 diff (99.7 %id)
DC299548		.a	1 to 572	2 to 574				574/574 (100 %)	2 diff (99.7 %id)
DC424884		.a	61 to 607	1 to 547				547/547 (100 %)	0 diff (100 %id)
AK313224		.a	61 to 1046	1 to 987	N199S			987/987 (100 %)	2 diff (99.8 %id)
DC300001		.a	61 to 616	1 to 557				557/557 (100 %)	2 diff (99.7 %id)
AL702949	human skeletal muscle	.a	61 to 817	1 to 753				753/755 (99 %)	7 diff (99.1 %id)
AL702945	human skeletal muscle	.a	61 to 807	1 to 747				747/754 (99 %)	3 diff (99.7 %id)
DC368138		.a	61 to 603	1 to 544				544/544 (100 %)	1 diff (99.9 %id)
DC349124		.a	62 to 625	1 to 576				576/576 (100 %)	11 diff (98.1 %id)
DC349389		.a	62 to 609	1 to 559				559/559 (100 %)	10 diff (98.3 %id)
DA654214		.a	62 to 641	2 to 582		capped		581/581 (100 %)	2 diff (99.7 %id)
DC364667		.a	62 to 625	1 to 565				565/565 (100 %)	1 diff (99.9 %id)
DC384692		.a	62 to 603	1 to 554				554/554 (100 %)	4 diff (99.3 %id)
DC425598		.a	62 to 624	1 to 563				563/563 (100 %)	1 diff (99.9 %id)
DA025467		.a	63 to 634	2 to 574		capped		573/573 (100 %)	1 diff (99.9 %id)
DA501626	brain	.a	63 to 632	2 to 571		capped		570/571 (99 %)	2 diff (99.7 %id)
DA660848		.a	63 to 641	2 to 580		tiling clone, capped		579/579 (100 %)	0 diff (100 %id)
DC299781		.a	64 to 495	1 to 434				434/436 (99 %)	4 diff (99.1 %id)
DW421223	Liver	.a	64 to 343	18 to 298				281/298 (94 %)	6 diff (98.0 %id)
DC367975		.a	64 to 611	1 to 547				547/547 (100 %)	2 diff (99.7 %id)
DC368988		.a	64 to 603	1 to 541				541/541 (100 %)	2 diff (99.7 %id)
DC413884	trachea	.a	64 to 566	1 to 505				505/505 (100 %)	2 diff (99.7 %id)
DA019825		.a	65 to 631	2 to 569		capped		568/568 (100 %)	1 diff (99.9 %id)
DA024456		.a	65 to 618	2 to 571		capped		570/570 (100 %)	11 diff (98.1 %id)
DA029233		.a	65 to 504	2 to 456		capped		455/455 (100 %)	11 diff (97.6 %id)
DA422022	cervix	.a	65 to 649	2 to 587		capped		586/586 (100 %)	1 diff (99.9 %id)
DA478749		.a	65 to 613	2 to 563		capped		562/562 (100 %)	10 diff (98.3 %id)
DA654311		.a	65 to 644	2 to 582		capped		581/581 (100 %)	1 diff (99.9 %id)
DA661700		.a	65 to 643	2 to 579		capped		578/578 (100 %)	2 diff (99.7 %id)
DA708323		.a	65 to 637	2 to 575		capped		574/574 (100 %)	2 diff (99.7 %id)
AL548164	placenta, Placenta Cot 25-normalized	.a	68 to 871	1 to 800		fully sequenced,		800/800 (100 %)	25 diff (96.9 %id)
TI_57179597		.a	68 to 792	32 to 759				728/760 (95 %)	9 diff (98.9 %id)
DB014515	esophageal, tumor tissue	.a	68 to 630	2 to 564		capped		563/563 (100 %)	1 diff (99.9 %id)
TI_57216540		.a	71 to 799	22 to 749				728/749 (97 %)	6 diff (99.2 %id)
BI771861	pooled lung and spleen	.a	72 to 792	1 to 724				724/725 (99 %)	5 diff (99.4 %id)
BQ440721	melanotic melanoma, skin	.a	72 to 872	12 to 815				804/815 (98 %)	6 diff (99.3 %id)
DR760284	embryonic stem	.a	72 to 869	1 to 796				796/796 (100 %)	2 diff (99.8 %id)
AL120912	melanoma (MeWo cell line)	.a	75 to 487	1 to 414				414/414 (100 %)	3 diff (99.3 %id)
CA391345	eye, RPE/choroid	.a	76 to 484	1 to 411				411/411 (100 %)	6 diff (98.6 %id)
BI832695	pooled pancreas and spleen	.a	76 to 738	1 to 660				633/718 (88 %)	56 diff (92.3 %id)
BU166125	melanotic melanoma, skin	.a	77 to 617	1 to 544				544/1065 (51 %)	8 diff (99.3 %id)
BI755890	brain	.a	78 to 799	1 to 721				721/721 (100 %)	2 diff (99.8 %id)
CN481689	eye	.a	79 to 662	24 to 620				597/620 (96 %)	6 diff (99.1 %id)
AA852857	Bone, Hip	.a	89 to 386	1 to 304				304/304 (100 %)	8 diff (97.4 %id)
DN994835	brain, whole brain	.a	89 to 793	8 to 715				708/715 (99 %)	6 diff (99.2 %id)
X97758		.a	90 to 2826	1 to 2745	exact	tiling clone,		2745/2745 (100 %)	16 diff (99.5 %id)
AW451979		.a	91 to 267	206 to 31		AAA		176/189 (93 %)	10 diff (94.8 %id)
AW452692		.a	91 to 267	206 to 31		AAA		176/189 (93 %)	12 diff (93.7 %id)
BF510053		.a	91 to 267	206 to 31		AAA		176/189 (93 %)	10 diff (94.8 %id)
BQ436975	melanotic melanoma, skin	.a	104 to 982	1 to 879				879/879 (100 %)	10 diff (98.9 %id)
U46459	liver cell line, pancreatic cancer	.a	129 to 497	1 to 374				374/374 (100 %)	5 diff (98.7 %id)
CN311453	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	136 to 399	1 to 265				265/265 (100 %)	3 diff (98.9 %id)
DC299594		.a	138 to 723	1 to 587				587/587 (100 %)	1 diff (99.9 %id)
TI_57164320		.a	196 to 1029	24 to 860				837/922 (90 %)	21 diff (97.8 %id)
BI833996	pooled pancreas and spleen	.a	197 to 1029	1 to 836				836/898 (93 %)	19 diff (97.9 %id)
BQ605321	breast	.a	239 to 745	507 to 1			Submitted on the opposite strand	507/507 (100 %)	10 diff (98.1 %id)
AL572822	placenta, Placenta Cot 25-normalized	.a	841 to 1817	976 to 1		fully sequenced,		976/976 (100 %)	15 diff (98.5 %id)
BI060364	uterus_tumor	.a	1220 to 1566	368 to 3				366/371 (98 %)	0 diff (100 %id)
DN915118		.a	1364 to 1731	1 to 365				365/368 (99 %)	5 diff (98.7 %id)
DA728262		.a	1375 to 2135	2 to 777		capped		776/804 (96 %)	12 diff (98.6 %id)
BI051800	placenta_normal	.a	1378 to 1589	214 to 2				213/219 (97 %)	0 diff (100 %id)
TI_149280761		.a	1378 to 2022	725 to 78		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	648/813 (79 %)	11 diff (98.7 %id)
CA311651	Human Lung Epithelial cells, lung	.a	1378 to 1798	440 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	422/467 (90 %)	1 diff (99.8 %id)
CN311456	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	1383 to 1926	1 to 545				545/545 (100 %)	3 diff (99.5 %id)
BE696013	colon	.a	1386 to 1896	510 to 1		tiling clone,		510/510 (100 %)	5 diff (99.1 %id)
BU198042	ectopic and normal uterine endometrium	.a	1390 to 1649	1 to 260				260/261 (99 %)	3 diff (98.9 %id)
CR597613	fetal brain	.a	1393 to 2835	1 to 1443		tiling clone,		1443/1443 (100 %)	0 diff (100 %id)
BX460517	brain, fetal brain	.a	1393 to 2340	1 to 948				948/948 (100 %)	16 diff (98.4 %id)
CN311459	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	1433 to 1967	1 to 535				535/535 (100 %)	3 diff (99.5 %id)
BM969930	lung, Primary Lung Epithelial Cells	.a	1439 to 2022	603 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	585/585 (100 %)	3 diff (99.5 %id)
H29347	whole brain	.a	1450 to 1876	1 to 431				431/431 (100 %)	6 diff (98.7 %id)
AA029235	uterus	.a	1459 to 1722	1 to 264				264/273 (96 %)	1 diff (99.7 %id)
R10814	liver and spleen	.a	1492 to 1807	1 to 323				323/323 (100 %)	12 diff (96.3 %id)
BF094408	uterus_tumor	.a	1499 to 1860	1 to 360				360/360 (100 %)	9 diff (97.5 %id)
BP289171	lung	.a	1499 to 2077	1 to 582				582/582 (100 %)	2 diff (99.7 %id)
BG997966	head_neck	.a	1500 to 1867	1 to 365				365/378 (96 %)	6 diff (98.5 %id)
BP315236	mammary gland	.a	1504 to 2087	1 to 583				583/583 (100 %)	1 diff (99.9 %id)
BQ355848	head_neck	.a	1510 to 1860	9 to 356				348/356 (97 %)	8 diff (97.8 %id)
BG989840	head_neck	.a	1512 to 1787	309 to 38				272/309 (88 %)	0 diff (100 %id)
CN311454	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	1514 to 2248	1 to 735				735/735 (100 %)	0 diff (100 %id)
T16826		.a	1533 to 1841	25 to 336				312/336 (92 %)	6 diff (98.3 %id)
AA953196	Kidney, kidney tumor	.a	1563 to 1850	289 to 1				289/289 (100 %)	1 diff (99.7 %id)
CN485192	eye	.a	1572 to 2208	1 to 637				637/637 (100 %)	0 diff (100 %id)
H11949	whole brain	.a	1573 to 2047	1 to 479			Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	479/481 (99 %)	11 diff (97.8 %id)
AI537513	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	1591 to 1807	217 to 1				217/217 (100 %)	0 diff (100 %id)
AA445965		.a	1593 to 2011	11 to 429			Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	419/429 (97 %)	6 diff (98.7 %id)
AA443435		.a	1596 to 2162	1 to 567			Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	567/567 (100 %)	1 diff (99.9 %id)
AW821812	stomach	.a	1623 to 2198	24 to 598				575/598 (96 %)	10 diff (98.4 %id)
BE937596	stomach	.a	1623 to 2198	24 to 598				575/598 (96 %)	10 diff (98.4 %id)
W24256	senescent fibroblast	.a	1701 to 2136	1 to 438				438/438 (100 %)	4 diff (99.1 %id)
W42968	senescent fibroblast	.a	1724 to 2163	1 to 443				443/443 (100 %)	6 diff (98.7 %id)
BM763305	myeloma	.a	1731 to 2347	1 to 617				617/617 (100 %)	0 diff (100 %id)
CN311457	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	1741 to 1883	1 to 143				143/143 (100 %)	1 diff (99.4 %id)
U46338	liver cell line, pancreatic cancer	.a	1806 to 2042	1 to 240				240/240 (100 %)	11 diff (95.5 %id)
BF693101	muscle (skeletal)	.a	1846 to 2533	1 to 673				673/874 (77 %)	53 diff (94.0 %id)
BP206345	coronary artery	.a	1861 to 2440	1 to 580				580/580 (100 %)	1 diff (99.9 %id)
BP207288	coronary artery	.a	1863 to 2445	1 to 582				582/582 (100 %)	17 diff (97.1 %id)
BP367060	thymus	.a	1882 to 2426	1 to 544				544/584 (93 %)	4 diff (99.4 %id)
TI_149313932		.a	1884 to 2835	1020 to 87		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	934/988 (94 %)	27 diff (97.3 %id)
AA010684	heart	.a	1890 to 2205	1 to 317				317/317 (100 %)	3 diff (99.1 %id)
CR739344	heart	.a	1891 to 2263	1 to 379				379/379 (100 %)	9 diff (97.7 %id)
TI_149284443		.a	1902 to 2361	525 to 69		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	457/1058 (43 %)	4 diff (99.7 %id)
BM984470	lung, Primary Lung Epithelial Cells	.a	1902 to 2361	473 to 17		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	457/462 (98 %)	4 diff (99.2 %id)
CA310945	Human Lung Epithelial cells, lung	.a	1902 to 2361	476 to 17		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	460/466 (98 %)	1 diff (99.8 %id)
BG314741		.a	1913 to 2027	1 to 115				115/115 (100 %)	0 diff (100 %id)
BE716834	head_neck	.a	1915 to 2235	331 to 13				319/340 (93 %)	0 diff (100 %id)
TI_149309787		.a	1916 to 2835	998 to 88		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	911/958 (95 %)	7 diff (99.3 %id)
TI_149306146		.a	1917 to 2834	993 to 85		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	909/978 (92 %)	21 diff (97.9 %id)
BX457996	neuroblastoma	.a	1922 to 2815	893 to 1				893/893 (100 %)	11 diff (98.8 %id)
BE789349	large cell carcinoma, lung	.a	1929 to 2646	1 to 721				721/844 (85 %)	14 diff (98.4 %id)
BX455105	brain, fetal brain	.a	1947 to 2830	888 to 4				885/888 (99 %)	0 diff (100 %id)
BM691483	eye, RPE and Choroid	.a	1949 to 2471	8 to 530				523/530 (98 %)	6 diff (98.9 %id)
FN067271	breast carcinoma	.a	1974 to 2067	1 to 91				91/92 (98 %)	4 diff (95.7 %id)
TI_154049627		.a	1978 to 2826	931 to 91		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	841/965 (87 %)	21 diff (97.9 %id)
AV655899	corresponding non cancerous liver tissue	.a	1987 to 2638	1 to 652			Submitted on the opposite strand	652/652 (100 %)	1 diff (99.9 %id)
BE695893	colon	.a	2016 to 2550	117 to 652				536/652 (82 %)	6 diff (99.1 %id)
TI_149301859		.a	2021 to 2835	888 to 83		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	806/941 (85 %)	15 diff (98.5 %id)
TI_149284109		.a	2028 to 2826	889 to 92		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	798/799 (99 %)	8 diff (99.0 %id)
BM845572	lymph node, stomach	.a	2048 to 2628	1 to 580				580/580 (100 %)	2 diff (99.7 %id)
BM845070	lymph node, stomach	.a	2048 to 2670	1 to 622				622/622 (100 %)	1 diff (99.9 %id)
BQ007830	Chondrosarcoma, Left Pelvis	.a	2057 to 2834	796 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	778/778 (100 %)	2 diff (99.8 %id)
CA314793	Human Lung Epithelial cells, lung	.a	2060 to 2826	786 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	768/768 (100 %)	6 diff (99.3 %id)
CA422962	cell lines, Chondrosarcoma	.a	2060 to 2835	793 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	775/775 (100 %)	3 diff (99.7 %id)
CA423225	cell lines, Chondrosarcoma	.a	2060 to 2826	785 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	767/767 (100 %)	3 diff (99.7 %id)
W16987	lung	.a	2070 to 2328	1 to 260				260/260 (100 %)	2 diff (99.3 %id)
BU616881	Cell Line, Chondrosarcoma	.a	2109 to 2835	746 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	728/728 (100 %)	2 diff (99.8 %id)
AA037435	uterus	.a	2113 to 2484	1 to 380		fully sequenced,		380/380 (100 %)	12 diff (96.9 %id)
W30971	senescent fibroblast	.a	2114 to 2660	1 to 551				551/554 (99 %)	16 diff (97.2 %id)
CA443828	Fibrosarcoma	.a	2116 to 2823	730 to 22		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	709/712 (99 %)	0 diff (100 %id)
BU943776	mixed (pool of 40 RNAs)	.a	2119 to 2824	1 to 706				706/707 (99 %)	7 diff (99.1 %id)
CA314803	Human Lung Epithelial cells, lung	.a	2124 to 2826	722 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	704/704 (100 %)	2 diff (99.8 %id)
BU629569	cell lines, Chondrosarcoma	.a	2127 to 2835	727 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	709/709 (100 %)	2 diff (99.8 %id)
BU686220	lung, Primary Lung Epithelial Cells	.a	2137 to 2834	713 to 16		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	698/698 (100 %)	1 diff (99.9 %id)
BU628110	Bone, Enchondroma cell line	.a	2141 to 2826	705 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	687/687 (100 %)	2 diff (99.8 %id)
CA421487	Chondrosarcoma Grade II, Left Pelvis	.a	2143 to 2826	698 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	680/680 (100 %)	8 diff (98.9 %id)
BU688155	lung	.a	2144 to 2835	711 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	693/693 (100 %)	1 diff (99.9 %id)
BM980147	lung, Primary Lung Cystic Fibrosis EpithelialCells	.a	2144 to 2835	711 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	693/693 (100 %)	2 diff (99.8 %id)
CA314525	Human Lung Epithelial cells, lung	.a	2147 to 2833	704 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	686/698 (98 %)	3 diff (99.6 %id)
TI_151714710		.a	2156 to 2826	819 to 139				681/1068 (63 %)	0 diff (100 %id)
BQ019859	Chondrosarcoma, Left Pubic Bone	.a	2162 to 2827	685 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	667/667 (100 %)	5 diff (99.3 %id)
CB305755	lung, Primary Lung Cystic Fibrosis EpithelialCells	.a	2162 to 2835	693 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	675/675 (100 %)	2 diff (99.8 %id)
N75094	multiple sclerosis lesions	.a	2166 to 2415	1 to 252		fully sequenced,		252/252 (100 %)	2 diff (99.3 %id)
TI_57230822		.a	2169 to 2827	54 to 710				657/746 (88 %)	7 diff (99.1 %id)
BI871681	adenocarcinoma, cell line, Liver	.a	2170 to 2827	1 to 656				656/670 (97 %)	7 diff (99.0 %id)
AA040883	uterus	.a	2177 to 2422	1 to 247				247/248 (99 %)	8 diff (96.8 %id)
BX409754	brain, fetal brain	.a	2178 to 2835	1 to 656				656/656 (100 %)	5 diff (99.3 %id)
BU680315	lung, Primary Lung Epithelial Cells	.a	2181 to 2826	665 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	647/647 (100 %)	3 diff (99.6 %id)
ES310442	scalp interfollicular dermis, skin	.a	2182 to 2827	684 to 41			Submitted on the opposite strand	644/687 (93 %)	0 diff (100 %id)
BU736064	eye, fetal eyes	.a	2224 to 2826	622 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	604/604 (100 %)	1 diff (99.9 %id)
CA413631	Chondrosarcoma Grade II, Left Pelvis	.a	2239 to 2826	608 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	590/590 (100 %)	2 diff (99.7 %id)
BQ067773	brain	.a	2245 to 2827	15 to 597				583/658 (88 %)	2 diff (99.7 %id)
BG314761		.a	2253 to 2368	116 to 1				116/117 (99 %)	0 diff (100 %id)
BG054844	brain, glioblastoma (pooled)	.a	2256 to 2826	572 to 1				572/572 (100 %)	1 diff (99.9 %id)
BQ018209	lung, Metastatic Chondrosarcoma	.a	2261 to 2823	585 to 22		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	564/567 (99 %)	0 diff (100 %id)
DN915119		.a	2284 to 2834	553 to 2				552/553 (99 %)	0 diff (100 %id)
DN919791		.a	2289 to 2824	539 to 3				537/539 (99 %)	0 diff (100 %id)
CD216783	lung	.a	2291 to 2834	1 to 545		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	545/546 (99 %)	2 diff (99.7 %id)
TI_151737563		.a	2297 to 2826	642 to 111				532/642 (82 %)	0 diff (100 %id)
BF438340	Prostate	.a	2300 to 2696	398 to 1				398/398 (100 %)	1 diff (99.8 %id)
AA587167	larynx	.a	2307 to 2676	370 to 1				370/370 (100 %)	0 diff (100 %id)
W69514	heart	.a	2308 to 2613	1 to 308		fully sequenced,	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	308/308 (100 %)	1 diff (99.7 %id)
AI963174	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2316 to 2827	515 to 2				514/515 (99 %)	0 diff (100 %id)
AW151025	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2316 to 2826	515 to 4				512/515 (99 %)	0 diff (100 %id)
AA082152	heart	.a	2317 to 2629	1 to 311				311/311 (100 %)	2 diff (99.4 %id)
AA528703	alveolar rhabdomyosarcoma	.a	2322 to 2838	523 to 6				518/523 (99 %)	0 diff (100 %id)
AI624405	adenocarcinoma, Pancreas	.a	2323 to 2835	514 to 1				514/514 (100 %)	2 diff (99.7 %id)
AI653778	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	2323 to 2826	505 to 1				505/505 (100 %)	1 diff (99.9 %id)
FN169496	breast carcinoma	.a	2325 to 2435	110 to 1			Submitted on the opposite strand	110/110 (100 %)	1 diff (99.1 %id)
CB243500	Human Lung Epithelial cells, lung	.a	2325 to 2823	521 to 22		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	500/512 (97 %)	0 diff (100 %id)
TI_154191631		.a	2334 to 2835	49 to 551		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	503/503 (100 %)	1 diff (99.9 %id)
CF127383	Chondrosarcoma Lung Metastasis cell lines, lung	.a	2336 to 2835	1 to 501		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	501/501 (100 %)	1 diff (99.9 %id)
AW474477	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	2337 to 2826	491 to 1				491/491 (100 %)	1 diff (99.8 %id)
AI453116	pooled	.a	2350 to 2838	495 to 6				490/495 (98 %)	0 diff (100 %id)
AI377033		.a	2355 to 2838	489 to 5				485/489 (99 %)	0 diff (100 %id)
AA010685	heart	.a	2359 to 2834	482 to 1				482/483 (99 %)	8 diff (98.4 %id)
AI818033	normal prostate, Prostate	.a	2360 to 2826	468 to 1				468/468 (100 %)	4 diff (99.2 %id)
AA594796	breast	.a	2367 to 2826	466 to 5				462/466 (99 %)	0 diff (100 %id)
AI569594	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	2371 to 2826	457 to 1				457/457 (100 %)	1 diff (99.8 %id)
C21363		.a	2373 to 2717	1 to 345				345/348 (99 %)	1 diff (99.8 %id)
H17505	whole brain	.a	2380 to 2826	464 to 9				456/468 (97 %)	0 diff (100 %id)
AI041658	senescent fibroblast	.a	2382 to 2816	436 to 1				436/436 (100 %)	1 diff (99.8 %id)
N52324	multiple sclerosis lesions	.a	2385 to 2836	458 to 1		fully sequenced,		458/458 (100 %)	4 diff (99.2 %id)
AW069228	bone marrow stroma	.a	2403 to 2834	451 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	433/433 (100 %)	1 diff (99.8 %id)
H29264	whole brain	.a	2404 to 2838	448 to 6				443/450 (98 %)	0 diff (100 %id)
CA444026	Fibrosarcoma	.a	2405 to 2823	441 to 22		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	420/423 (99 %)	0 diff (100 %id)
CA443767	lung, Metastatic Chondrosarcoma	.a	2406 to 2835	448 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	430/430 (100 %)	3 diff (99.4 %id)
AA029236	uterus	.a	2407 to 2835	435 to 1				435/435 (100 %)	6 diff (98.7 %id)
N71756	melanocyte	.a	2411 to 2826	429 to 1				429/431 (99 %)	11 diff (97.5 %id)
BF939705	brain, glioblastoma (pooled)	.a	2412 to 2823	416 to 5				412/416 (99 %)	0 diff (100 %id)
AI129127	senescent fibroblast	.a	2414 to 2826	428 to 15		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	414/414 (100 %)	1 diff (99.8 %id)
AI587174	adenocarcinoma, Pancreas	.a	2414 to 2827	432 to 16		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	417/417 (100 %)	6 diff (98.6 %id)
AI624070	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2416 to 2826	414 to 4				411/414 (99 %)	0 diff (100 %id)
AA430018		.a	2427 to 2835	424 to 15		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	410/410 (100 %)	1 diff (99.8 %id)
C75191		.a	2433 to 2801	369 to 1				369/369 (100 %)	0 diff (100 %id)
BP425026	small intestine	.a	2436 to 2827	1 to 395			Submitted on the opposite strand	395/395 (100 %)	3 diff (99.3 %id)
AI752975	bone marrow stroma	.a	2438 to 2835	417 to 18		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	400/400 (100 %)	2 diff (99.5 %id)
AI446683	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	2444 to 2837	395 to 1				395/395 (100 %)	1 diff (99.8 %id)
T16825		.a	2444 to 2826	384 to 1				384/384 (100 %)	1 diff (99.8 %id)
CN311460	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	2447 to 2827	10 to 391		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	382/391 (97 %)	6 diff (98.5 %id)
CD676726	eye, Trabecular meshwork	.a	2452 to 2808	1 to 357		AAA		357/372 (95 %)	6 diff (98.4 %id)
AI143000	senescent fibroblast	.a	2452 to 2826	385 to 10				376/385 (97 %)	0 diff (100 %id)
CB048790	Prostate	.a	2453 to 2833	10 to 390		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	381/390 (97 %)	6 diff (98.5 %id)
AA037493	uterus	.a	2454 to 2827	379 to 1		fully sequenced,		379/379 (100 %)	2 diff (99.5 %id)
AI613239	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.a	2454 to 2826	375 to 2				374/375 (99 %)	0 diff (100 %id)
AW073733	2 pooled high-grade transitional celltumors, genitourinary tract	.a	2455 to 2826	373 to 1				373/373 (100 %)	2 diff (99.5 %id)
AA948343	2 pooled tumors (clear cell type), Kidney	.a	2456 to 2838	384 to 1				384/384 (100 %)	1 diff (99.8 %id)
CN311458	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	2458 to 2826	1 to 370		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	370/370 (100 %)	1 diff (99.8 %id)
AA969758	2 pooled tumors (clear cell type), Kidney	.a	2458 to 2835	379 to 1				379/379 (100 %)	1 diff (99.8 %id)
AI750200	Bone, Hip	.a	2458 to 2805	344 to 10				335/344 (97 %)	0 diff (100 %id)
AA443302		.a	2481 to 2835	370 to 15		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	356/356 (100 %)	1 diff (99.8 %id)
AA908310	ovary, serous adenocarcinoma	.a	2483 to 2826	345 to 1				345/345 (100 %)	1 diff (99.8 %id)
AA918635	Kidney	.a	2491 to 2826	338 to 2				337/338 (99 %)	0 diff (100 %id)
AA865225	2 pooled tumors (clear cell type), Kidney	.a	2492 to 2838	348 to 1				348/348 (100 %)	1 diff (99.8 %id)
AA852858	Bone, Hip	.a	2496 to 2788	300 to 8				293/300 (97 %)	0 diff (100 %id)
BP388593	pancreatic islet	.a	2498 to 2787	1 to 292			Submitted on the opposite strand	292/292 (100 %)	2 diff (99.4 %id)
AI247214	Kidney	.a	2510 to 2838	327 to 1				327/352 (92 %)	8 diff (97.8 %id)
AI303019	2 pooled tumors (clear cell type), Kidney	.a	2510 to 2826	321 to 4				318/321 (99 %)	0 diff (100 %id)
R10718	liver and spleen	.a	2515 to 2824	318 to 1				318/348 (91 %)	11 diff (96.9 %id)
AI953533	normal epithelium, ovary	.a	2541 to 2835	296 to 1				296/296 (100 %)	1 diff (99.7 %id)
T30006	adipose	.a	2546 to 2803	262 to 5				258/262 (98 %)	0 diff (100 %id)
N98483	senescent fibroblast	.a	2578 to 2826	256 to 7				250/256 (97 %)	0 diff (100 %id)
W42969	senescent fibroblast	.a	2583 to 2811	230 to 1				230/230 (100 %)	1 diff (99.6 %id)
W69431	heart	.a	2583 to 2826	268 to 23		fully sequenced, AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	246/246 (100 %)	1 diff (99.6 %id)
AW798430	uterus	.a	2584 to 2845	7 to 268		tiling clone,		262/269 (97 %)	5 diff (98.2 %id)
H11950	whole brain	.a	2592 to 2826	261 to 25		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	237/237 (100 %)	6 diff (97.5 %id)
AA877385	2 pooled tumors (clear cell type), Kidney	.a	2611 to 2838	233 to 5				229/233 (98 %)	0 diff (100 %id)
N66700	multiple sclerosis lesions	.a	2664 to 2838	177 to 2				176/182 (96 %)	0 diff (100 %id)
AI288055	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2695 to 2835	142 to 1				142/142 (100 %)	1 diff (99.3 %id)
DA475785		.b	1 to 568	2 to 569		tiling clone, capped		568/568 (100 %)	0 diff (100 %id)
BP230174	brain	.b	32 to 613	1 to 582				582/582 (100 %)	3 diff (99.5 %id)
DC367501		.b	33 to 531	1 to 499				499/499 (100 %)	0 diff (100 %id)
BP231639	muscle	.b	34 to 614	1 to 583				583/583 (100 %)	8 diff (98.7 %id)
CB960665	Human Placenta, placenta	.b	56 to 755	22 to 729				708/764 (92 %)	20 diff (97.4 %id)
CF594049	Human Placenta, placenta	.b	56 to 795	23 to 762				740/845 (87 %)	9 diff (99.0 %id)
DC373873	tongue	.b	59 to 629	1 to 571				571/571 (100 %)	0 diff (100 %id)
DC375215	brain	.b	59 to 630	1 to 572				572/572 (100 %)	2 diff (99.7 %id)
DN919792		.b	61 to 176	1 to 116				116/116 (100 %)	2 diff (98.3 %id)
DC375629	brain	.b	61 to 630	1 to 570				570/570 (100 %)	0 diff (100 %id)
DC384807		.b	61 to 629	1 to 569				569/569 (100 %)	0 diff (100 %id)
DW461485	Liver	.b	62 to 170	18 to 126				109/127 (85 %)	1 diff (99.3 %id)
DC357556		.b	62 to 647	1 to 586				586/586 (100 %)	0 diff (100 %id)
DC425154		.b	62 to 625	1 to 564				564/564 (100 %)	0 diff (100 %id)
AU280574		.b	62 to 632	1 to 571				571/571 (100 %)	0 diff (100 %id)
DC421344	uterus	.b	62 to 623	1 to 562				562/562 (100 %)	1 diff (99.9 %id)
DC350115	brain	.b	63 to 517	1 to 455				455/455 (100 %)	0 diff (100 %id)
NM_005168.3		.b	63 to 2745	1 to 2683	exact	RefSeq,		2683/2683 (100 %)	0 diff (100 %id)
BP354466		.b	63 to 644	1 to 582				582/582 (100 %)	4 diff (99.4 %id)
DC299129		.b	64 to 630	1 to 567				567/567 (100 %)	0 diff (100 %id)
DC299221		.b	64 to 626	1 to 563				563/563 (100 %)	0 diff (100 %id)
DC299260		.b	64 to 642	1 to 579				579/579 (100 %)	1 diff (99.9 %id)
DC299471		.b	64 to 631	1 to 568				568/568 (100 %)	1 diff (99.9 %id)
DC300002		.b	64 to 639	1 to 576				576/576 (100 %)	0 diff (100 %id)
DC300044		.b	64 to 635	1 to 572				572/572 (100 %)	0 diff (100 %id)
DC300836	bladder	.b	64 to 625	1 to 562				562/562 (100 %)	0 diff (100 %id)
DC424969		.b	64 to 633	1 to 570				570/570 (100 %)	0 diff (100 %id)
DC346431	tongue, tumor tissue	.b	64 to 650	1 to 587				587/587 (100 %)	0 diff (100 %id)
DC348592		.b	64 to 624	1 to 561				561/561 (100 %)	0 diff (100 %id)
DC349130		.b	64 to 628	1 to 565				565/565 (100 %)	0 diff (100 %id)
BP229813	brain	.b	64 to 645	1 to 582				582/582 (100 %)	0 diff (100 %id)
DC353118	brain	.b	64 to 623	1 to 560				560/560 (100 %)	0 diff (100 %id)
DC354082	brain	.b	64 to 641	1 to 578				578/578 (100 %)	0 diff (100 %id)
DC355046		.b	64 to 634	1 to 571				571/571 (100 %)	0 diff (100 %id)
DC355161		.b	64 to 632	1 to 572				572/572 (100 %)	3 diff (99.5 %id)
DC356378		.b	64 to 622	1 to 559				559/559 (100 %)	0 diff (100 %id)
BP237162	coronary artery	.b	64 to 646	1 to 583				583/583 (100 %)	3 diff (99.5 %id)
DC357961		.b	64 to 624	1 to 561				561/561 (100 %)	0 diff (100 %id)
DC358081		.b	64 to 635	1 to 572				572/572 (100 %)	1 diff (99.9 %id)
DC358460	lung	.b	64 to 409	1 to 346				346/346 (100 %)	0 diff (100 %id)
DC358784	lung	.b	64 to 659	1 to 596				596/596 (100 %)	1 diff (99.9 %id)
BP279429		.b	64 to 645	1 to 582				582/582 (100 %)	7 diff (98.8 %id)
DC363491		.b	64 to 634	1 to 571				571/571 (100 %)	1 diff (99.9 %id)
DC364296		.b	64 to 629	1 to 566				566/566 (100 %)	0 diff (100 %id)
DC428479		.b	64 to 609	1 to 546				546/546 (100 %)	1 diff (99.9 %id)
DC368746		.b	64 to 619	1 to 556				556/556 (100 %)	1 diff (99.9 %id)
DC368845		.b	64 to 524	1 to 461				461/461 (100 %)	3 diff (99.4 %id)
DC375805	brain	.b	64 to 241	1 to 178				178/178 (100 %)	0 diff (100 %id)
DC379830	pericardium	.b	64 to 624	1 to 561				561/561 (100 %)	0 diff (100 %id)
DC384555		.b	64 to 638	1 to 575				575/575 (100 %)	0 diff (100 %id)
BP339154	Spleen	.b	64 to 633	1 to 570				570/570 (100 %)	0 diff (100 %id)
BP345044	synovial membrane	.b	64 to 644	1 to 581				581/581 (100 %)	2 diff (99.7 %id)
DC425667		.b	64 to 618	1 to 555				555/555 (100 %)	1 diff (99.9 %id)
DC409204	thymus	.b	64 to 621	1 to 558				558/558 (100 %)	1 diff (99.9 %id)
DC414084	trachea	.b	64 to 642	1 to 579				579/579 (100 %)	0 diff (100 %id)
DC414168	trachea	.b	64 to 529	1 to 466				466/466 (100 %)	1 diff (99.8 %id)
DC420314	uterus	.b	64 to 521	1 to 458				458/458 (100 %)	1 diff (99.8 %id)
DA021968		.b	65 to 539	2 to 476		capped		475/475 (100 %)	0 diff (100 %id)
DA649510		.b	65 to 597	2 to 534		capped		533/533 (100 %)	0 diff (100 %id)
DA651532		.b	65 to 599	2 to 536		capped		535/535 (100 %)	0 diff (100 %id)
DA662767		.b	65 to 592	2 to 529		capped		528/528 (100 %)	0 diff (100 %id)
DA766894	tongue	.b	65 to 579	2 to 516		capped		515/515 (100 %)	1 diff (99.9 %id)
DA787710	brain	.b	65 to 566	2 to 503		capped		502/510 (98 %)	0 diff (100 %id)
DC365839		.b	66 to 619	1 to 554				554/554 (100 %)	0 diff (100 %id)
DC371198		.b	66 to 632	1 to 567				567/567 (100 %)	0 diff (100 %id)
BP258412	heart	.b	67 to 632	1 to 565				565/565 (100 %)	22 diff (96.2 %id)
DC355265		.b	68 to 641	1 to 574				574/574 (100 %)	2 diff (99.7 %id)
DC363211		.b	68 to 610	1 to 543				543/543 (100 %)	0 diff (100 %id)
DB194779	trachea	.b	68 to 596	2 to 530		capped		529/529 (100 %)	0 diff (100 %id)
BG117409	adenocarcinoma, cell line, Liver	.b	72 to 773	1 to 703				703/1098 (64 %)	11 diff (99.0 %id)
BC012513	Kidney, hypernephroma	.b	79 to 2742	1 to 2667	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	2667/2667 (100 %)	3 diff (99.9 %id)
BG118494	adenocarcinoma, cell line, Liver	.b	80 to 853	1 to 774				774/853 (90 %)	8 diff (99.1 %id)
BG165500	hypernephroma, cell line, Kidney	.b	80 to 702	1 to 648				582/696 (83 %)	38 diff (94.6 %id)
AA115811	colon, tumor	.b	86 to 492	1 to 414			Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	414/414 (100 %)	8 diff (98.1 %id)
CN484360	eye	.b	89 to 699	1 to 611				611/611 (100 %)	0 diff (100 %id)
TI_57242490		.b	89 to 745	69 to 725				657/726 (90 %)	9 diff (98.8 %id)
N44809	melanocyte	.b	92 to 316	1 to 225				225/230 (97 %)	2 diff (99.2 %id)
BI917896	brain	.b	93 to 745	1 to 653				653/654 (99 %)	3 diff (99.6 %id)
BY795113	eye	.b	97 to 686	1 to 590				590/590 (100 %)	0 diff (100 %id)
DB015304	esophageal, tumor tissue	.b	103 to 566	2 to 464		capped		463/471 (98 %)	4 diff (99.2 %id)
BP365551	lung	.b	111 to 689	1 to 578				578/578 (100 %)	3 diff (99.5 %id)
DA034012		.b	117 to 689	2 to 574		capped		573/573 (100 %)	0 diff (100 %id)
T58202	fetal spleen, Spleen	.b	125 to 450	1 to 331				331/331 (100 %)	7 diff (97.9 %id)
W86282	liver and spleen	.b	172 to 654	1 to 491			Submitted on the opposite strand	491/491 (100 %)	9 diff (98.2 %id)
BF509678		.b	172 to 668	15 to 511			Submitted on the opposite strand	497/497 (100 %)	4 diff (99.2 %id)
AA777317	liver and spleen	.b	178 to 665	1 to 488			Submitted on the opposite strand	488/488 (100 %)	1 diff (99.8 %id)
W88811	liver and spleen	.b	189 to 594	1 to 412			Submitted on the opposite strand	412/413 (99 %)	8 diff (98.1 %id)
CB565891	mixed	.b	217 to 953	1 to 737	exact			737/738 (99 %)	2 diff (99.8 %id)
AF498969	placenta	.b	219 to 953	1 to 735	exact			735/735 (100 %)	0 diff (100 %id)
BT006769		.b	219 to 951	1 to 733				733/735 (99 %)	1 diff (99.9 %id)
CV023988	mixed	.b	219 to 899	1 to 680				680/680 (100 %)	1 diff (99.9 %id)
TI_1948101010		.b	219 to 649	121 to 551		fully sequenced, AAA		431/551 (78 %)	6 diff (99.0 %id)
TI_1948101157		.b	219 to 559	129 to 469				341/368 (92 %)	6 diff (98.4 %id)
TI_1948101304		.b	219 to 566	129 to 476				348/384 (90 %)	6 diff (98.5 %id)
TI_1948101437		.b	219 to 527	123 to 431		fully sequenced,		309/431 (71 %)	6 diff (98.7 %id)
X95282	Spleen	.b	219 to 953	1 to 735	exact			735/735 (100 %)	0 diff (100 %id)
S82240		.b	240 to 1073	1 to 833				833/833 (100 %)	1 diff (99.9 %id)
BF928578	nervous_tumor	.b	254 to 495	249 to 10			Submitted on the opposite strand	240/249 (96 %)	1 diff (99.6 %id)
CR542038		.b	264 to 953	1 to 690				690/690 (100 %)	1 diff (99.9 %id)
CR542070		.b	264 to 950	1 to 687				687/687 (100 %)	0 diff (100 %id)
BQ720259	sympathetic trunk	.b	265 to 1137	1 to 874				874/875 (99 %)	12 diff (98.7 %id)
BG314793		.b	272 to 406	1 to 136				136/136 (100 %)	3 diff (97.8 %id)
BF171044	blood	.b	295 to 603	1 to 305				305/306 (99 %)	9 diff (97.1 %id)
DA438929	tongue, tumor tissue	.b	300 to 883	2 to 585		capped		584/584 (100 %)	0 diff (100 %id)
DB174732	kidney, tumor tissue	.b	330 to 895	2 to 567		capped		566/566 (100 %)	0 diff (100 %id)
DA576349		.b	410 to 969	2 to 561		capped		560/560 (100 %)	0 diff (100 %id)
BP266706	thyroid	.b	414 to 994	1 to 581				581/581 (100 %)	1 diff (99.9 %id)
DR762097	embryonic stem	.b	419 to 1237	1 to 819				819/819 (100 %)	5 diff (99.4 %id)
W88810	liver and spleen	.b	436 to 865	430 to 1			Submitted on the opposite strand	430/431 (99 %)	6 diff (98.7 %id)
BP291050	lung	.b	436 to 1018	1 to 583				583/583 (100 %)	1 diff (99.9 %id)
DA475660		.b	452 to 1006	2 to 556		capped		555/555 (100 %)	0 diff (100 %id)
AI750201	Bone, Hip	.b	461 to 873	1 to 412				412/412 (100 %)	6 diff (98.6 %id)
W86326	liver and spleen	.b	462 to 890	435 to 1			Submitted on the opposite strand	435/438 (99 %)	8 diff (98.2 %id)
H96700	melanocyte	.b	470 to 608	1 to 139				139/145 (95 %)	2 diff (98.7 %id)
DB199467	trachea	.b	470 to 1043	2 to 575		capped		574/574 (100 %)	0 diff (100 %id)
BQ880029	dorsal root ganglia	.b	478 to 1325	19 to 872				854/880 (97 %)	25 diff (97.2 %id)
CN311452	embryonic stem cells, cell lines H1, H7, andH9	.b	485 to 1000	1 to 517				517/517 (100 %)	1 diff (99.9 %id)
TI_1948101438		.b	497 to 952	578 to 123		fully sequenced,		456/578 (78 %)	0 diff (100 %id)
DA577079		.b	499 to 1059	2 to 562		capped		561/561 (100 %)	0 diff (100 %id)
BF733742	amnion_normal	.b	512 to 858	357 to 11			Submitted on the opposite strand	347/357 (97 %)	1 diff (99.8 %id)
DA997934		.b	519 to 1066	2 to 549		capped		548/548 (100 %)	0 diff (100 %id)
BQ303210	breast	.b	520 to 903	425 to 41				385/425 (90 %)	0 diff (100 %id)
DA600104		.b	521 to 1066	2 to 547		capped		546/546 (100 %)	1 diff (99.9 %id)
CU442895	epidermis	.b	527 to 1144	625 to 8			Submitted on the opposite strand	618/627 (98 %)	4 diff (99.4 %id)
CU444242	epidermis	.b	527 to 1144	625 to 8			Submitted on the opposite strand	618/627 (98 %)	4 diff (99.4 %id)
BE170512	head_neck	.b	537 to 684	13 to 161				149/165 (90 %)	8 diff (95.2 %id)
BG260108	bladder, transitional cell papilloma, cell line	.b	574 to 1171	1 to 604				604/1236 (48 %)	11 diff (99.2 %id)
DA748774		.b	604 to 1162	2 to 559		capped		558/565 (98 %)	1 diff (99.9 %id)
AU120255	whole embryo, mainly body	.b	608 to 1299	2 to 693		capped		692/700 (98 %)	9 diff (98.8 %id)
TI_1948101011		.b	619 to 952	460 to 127		fully sequenced,		334/460 (72 %)	0 diff (100 %id)
AW580862	leiomios	.b	620 to 1081	1 to 467				467/467 (100 %)	24 diff (94.9 %id)
CB266344	adipose	.b	620 to 1185	1 to 566				566/566 (100 %)	0 diff (100 %id)
BQ879015	dorsal root ganglia	.b	623 to 1516	1 to 897				897/897 (100 %)	3 diff (99.7 %id)
BP291720	lung	.b	625 to 1205	1 to 581				581/581 (100 %)	2 diff (99.7 %id)
TI_1948101158		.b	629 to 952	448 to 125				324/351 (92 %)	0 diff (100 %id)
BX431772	fetal liver, Liver	.b	644 to 1542	1 to 906				906/906 (100 %)	20 diff (97.8 %id)
TI_1948101305		.b	650 to 952	422 to 120				303/330 (91 %)	0 diff (100 %id)
DA485087	brain	.b	653 to 1231	2 to 580		capped		579/579 (100 %)	1 diff (99.9 %id)
CN311450	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.b	673 to 1275	1 to 604				604/604 (100 %)	2 diff (99.7 %id)
AW385723	leiomios	.b	699 to 1170	21 to 489				469/498 (94 %)	10 diff (98.0 %id)
BX345598	Placenta Cot 25-normalized	.b	702 to 1670	974 to 1				974/974 (100 %)	59 diff (94.0 %id)
AV647608	corresponding non cancerous liver tissue	.b	722 to 1359	1 to 633			Submitted on the opposite strand	633/633 (100 %)	22 diff (96.6 %id)
CU452984	epidermis	.b	735 to 1144	417 to 8			Submitted on the opposite strand	410/417 (98 %)	0 diff (100 %id)
BQ695270	adipose	.b	737 to 1198	1 to 462				462/462 (100 %)	2 diff (99.6 %id)
DA576484		.b	739 to 1287	2 to 550		capped		549/549 (100 %)	0 diff (100 %id)
DA931083	small intestine	.b	744 to 1317	2 to 580		capped		579/579 (100 %)	3 diff (99.5 %id)
CU451841	epidermis	.b	756 to 1144	396 to 8			Submitted on the opposite strand	389/396 (98 %)	0 diff (100 %id)
CA390876	eye, RPE/choroid	.b	762 to 1382	1 to 624				624/624 (100 %)	1 diff (99.9 %id)
AU310273	neuroblastoma	.b	765 to 1334	1 to 571				571/571 (100 %)	1 diff (99.9 %id)
DA549491		.b	767 to 1332	2 to 569		capped		568/568 (100 %)	3 diff (99.5 %id)
F12790	brain, total brain	.b	770 to 1068	1 to 299				299/299 (100 %)	0 diff (100 %id)
BQ009500	Chondrosarcoma, Left Pubic Bone	.b	775 to 1330	576 to 20		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	557/557 (100 %)	22 diff (96.1 %id)
CD677063	eye, Trabecular meshwork	.b	778 to 1380	1 to 603				603/603 (100 %)	2 diff (99.7 %id)
BP337531	coronary artery	.b	792 to 1377	1 to 585				585/587 (99 %)	19 diff (96.8 %id)
T75089	whole brain	.b	812 to 1078	1 to 267				267/267 (100 %)	4 diff (98.6 %id)
CN311451	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.b	821 to 1489	1 to 672				672/672 (100 %)	3 diff (99.6 %id)
CN311455	embryonic stem cells, DMSO-treated H9 cellline	.b	824 to 1487	9 to 673				665/673 (98 %)	6 diff (99.2 %id)
BE813011	amnion_normal	.b	829 to 1365	1 to 538				538/543 (99 %)	6 diff (98.9 %id)
BX495381	Liver	.b	834 to 1337	1 to 505				505/505 (100 %)	3 diff (99.5 %id)
DA370960	thalamus	.b	844 to 1393	2 to 552		capped		551/551 (100 %)	2 diff (99.7 %id)
FN046555	breast carcinoma	.b	845 to 898	1 to 55				55/55 (100 %)	1 diff (98.2 %id)
BP342739	stomach mucosa	.b	847 to 1344	1 to 500				500/518 (96 %)	6 diff (98.9 %id)
BP417547	small intestine	.b	854 to 1211	1 to 358			Submitted on the opposite strand	358/358 (100 %)	1 diff (99.8 %id)
AA093817		.b	863 to 1027	1 to 159				159/163 (97 %)	11 diff (93.3 %id)
BQ307485	breast	.b	867 to 1212	1 to 347				347/347 (100 %)	7 diff (98.0 %id)
FN103019	breast carcinoma	.b	874 to 954	80 to 1			Submitted on the opposite strand	80/81 (98 %)	1 diff (98.8 %id)
DA569957	whole embryo, mainly head	.b	911 to 1650	2 to 750		capped		749/775 (96 %)	17 diff (97.9 %id)
BG290293	bladder, transitional cell papilloma, cell line	.b	929 to 1623	1 to 723				723/723 (100 %)	67 diff (90.8 %id)
CN311449	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.b	935 to 1352	8 to 428				421/428 (98 %)	6 diff (98.6 %id)
AV652953	corresponding non cancerous liver tissue	.b	935 to 1359	1 to 426			Submitted on the opposite strand	426/426 (100 %)	1 diff (99.8 %id)
BI059524	uterus_tumor	.b	958 to 1397	443 to 1				443/443 (100 %)	11 diff (97.6 %id)
CD709529	normal nasopharynx	.b	978 to 1458	33 to 515				483/515 (93 %)	6 diff (98.9 %id)
BQ000191	Fibrosarcoma	.b	993 to 1708	736 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	718/718 (100 %)	2 diff (99.8 %id)
CA427453	Cell Line, Chondrosarcoma	.b	993 to 1714	743 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	725/725 (100 %)	2 diff (99.8 %id)
BU622014	Cell Line, Chondrosarcoma	.b	1006 to 1714	730 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	712/712 (100 %)	2 diff (99.8 %id)
BP261885	small intestine	.b	1030 to 1608	1 to 583				583/583 (100 %)	3 diff (99.5 %id)
CA310320	Alveolar Macrophage, lung	.b	1037 to 1779	765 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	747/747 (100 %)	2 diff (99.8 %id)
AA248057		.b	1040 to 1180	1 to 138				138/142 (97 %)	6 diff (95.8 %id)
TI_154100168		.b	1055 to 1714	758 to 97		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	662/663 (99 %)	1 diff (99.9 %id)
CA441213	Fibrosarcoma	.b	1078 to 1714	657 to 19		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	639/639 (100 %)	1 diff (99.9 %id)
BP261487	small intestine	.b	1136 to 1712	1 to 579				579/579 (100 %)	4 diff (99.4 %id)
BP290231	lung	.b	1143 to 1606	1 to 464				464/569 (81 %)	30 diff (94.8 %id)
DA568151	whole embryo, mainly head	.b	1153 to 1884	2 to 739		tiling clone, capped		738/749 (98 %)	7 diff (99.1 %id)
BM759532	Ascites, stomach	.b	1157 to 1681	1 to 526				526/526 (100 %)	7 diff (98.7 %id)
BP268595	thyroid	.b	1199 to 1768	1 to 573				573/573 (100 %)	4 diff (99.4 %id)
BP269154	thyroid	.b	1199 to 1779	1 to 584				584/584 (100 %)	7 diff (98.9 %id)
H96577	melanocyte	.b	1201 to 1632	441 to 1				441/442 (99 %)	8 diff (98.2 %id)
AW518693	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.b	1262 to 1716	456 to 3				454/456 (99 %)	0 diff (100 %id)
DB354628	whole embryo, mainly head	.b	2175 to 2742	565 to 1		tiling clone,		565/567 (99 %)	17 diff (97.1 %id)
DB358915	whole embryo, mainly body	.b	2175 to 2733	559 to 1				559/560 (99 %)	24 diff (95.8 %id)
DB356676	whole embryo, mainly head	.b	2185 to 2742	559 to 1				559/563 (99 %)	16 diff (97.2 %id)
AA115812	colon, tumor	.b	2305 to 2742	456 to 11		AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	446/448 (99 %)	10 diff (97.8 %id)
N35505	melanocyte	.b	2308 to 2733	431 to 1				431/431 (100 %)	5 diff (98.9 %id)
R38527	whole brain	.b	2380 to 2724	360 to 3				358/363 (98 %)	0 diff (100 %id)
CR607069	Placenta Cot 25-normalized	.c	1 to 1747	1 to 1747	exact	tiling clone,		1747/1747 (100 %)	0 diff (100 %id)
CR626467	Placenta Cot 25-normalized	.c	6 to 1693	1 to 1688	exact			1688/1688 (100 %)	0 diff (100 %id)
BQ434193	melanotic melanoma, skin	.d	1 to 879	1 to 882	exact	tiling clone,		882/884 (99 %)	15 diff (98.4 %id)
DC352008	brain	.e	1 to 568	4 to 571	exact	tiling clone,		571/571 (100 %)	1 diff (99.9 %id)
DC347036	tongue, tumor tissue	.f	1 to 545	24 to 570	exact	tiling clone,		547/570 (95 %)	6 diff (99.0 %id)
DA777233	brain	.g	1 to 504	2 to 505	L73S S112R	tiling clone, capped		504/509 (99 %)	3 diff (99.5 %id)
DC376415	brain	.h	1 to 452	1 to 454	M75N L76A V78G G79R C80L ...	tiling clone,		454/461 (98 %)	3 diff (99.4 %id)
BE178611	head_neck	.i	1 to 445	448 to 3		tiling clone,	Submitted on the opposite strand	446/450 (99 %)	0 diff (100 %id)
BE004578	breast_normal	.i	4 to 450	4 to 448		tiling clone,		445/448 (99 %)	6 diff (98.7 %id)
AW804054	uterus	.i	27 to 448	422 to 1				422/422 (100 %)	0 diff (100 %id)
AW804058	uterus	.i	50 to 387	330 to 1		tiling clone,		330/393 (83 %)	10 diff (97.5 %id)
CV346696	breast_normal	.i	62 to 240	46 to 228				183/228 (80 %)	6 diff (97.4 %id)
AL602713	human skeletal muscle	.i	231 to 846	1 to 615		tiling clone,		615/615 (100 %)	1 diff (99.9 %id)
CV346716	breast_normal	.i	357 to 459	109 to 5			Submitted on the opposite strand	105/125 (84 %)	0 diff (100 %id)
BF841192	head_neck	.i	579 to 1010	447 to 16	N35I M36W A37P K38N Q39R ...	tiling clone,	Submitted on the opposite strand	432/447 (96 %)	19 diff (95.8 %id)
AK309442	brain	.j	1 to 888	2 to 889	exact	tiling clone,		889/889 (100 %)	0 diff (100 %id)
DA532407	brain	.j	1 to 578	2 to 579		capped		578/578 (100 %)	0 diff (100 %id)
DA854831	placenta	.k-u	1 to 586	2 to 585	L5F S48F F49H I50S V51G ...	tiling clone, capped		584/584 (100 %)	2 diff (99.7 %id)
DW431427	Liver	.l-u	1 to 225	18 to 243	exact	AAA		226/243 (93 %)	6 diff (97.6 %id)
DW441250	Liver	.l-u	1 to 365	18 to 379	exact	tiling clone,		362/379 (95 %)	6 diff (98.5 %id)
DW441251	Liver	.l-u	1 to 361	18 to 379	exact	tiling clone,		362/379 (95 %)	10 diff (97.4 %id)
AA603081	normal prostate, Prostate	.l-u	212 to 490	310 to 34		tiling clone, AAA	Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base)	277/277 (100 %)	10 diff (96.4 %id)
DW433898	Liver	.l-u	250 to 493	17 to 260		tiling clone,		244/260 (93 %)	6 diff (97.7 %id)
AA329173		.m	1 to 226	1 to 225	S32P K33R N34I	tiling clone,		225/264 (85 %)	4 diff (98.5 %id)
R18107	liver and spleen	.m	109 to 459	12 to 366				358/366 (97 %)	11 diff (97.0 %id)
R10249	liver and spleen	.m	109 to 474	14 to 385		tiling clone,		372/404 (92 %)	13 diff (96.8 %id)
H69633	liver and spleen	.m	111 to 461	1 to 353		tiling clone,		353/353 (100 %)	2 diff (99.5 %id)
BE185205	head_neck	.n-u	1 to 214	1 to 214	exact	tiling clone,		214/223 (95 %)	3 diff (98.7 %id)
AK298007	lung	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
AK299731	brain	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
AK311312	brain	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
DC349662	brain	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
AV646935	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand
AV646936	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand
AV647514	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand
AV647555	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand, submitted on the opposite strand
AV647774	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand
AV653593	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand, submitted on the opposite strand
AV654752	corresponding non cancerous liver tissue	Gene RND3, variant not shown					Submitted on the opposite strand, submitted on the opposite strand
BJ990266	hepatoblastoma	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
BJ990267	hepatoblastoma	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
DC358322	lung	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
N67837	melanocyte	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
W03441	melanocyte	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
CD643122	Embryonic Stem cells	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored
CD651943	Embryonic Stem cells	Gene RND3, variant not shown					Suspected internal deletion, this clone was ignored